Neonatal dexamethasone treatment exacerbates hypoxic-ischemic brain injury

BACKGROUND: The synthetic glucocorticoid dexamethasone (DEX) is commonly used to prevent chronic lung disease in prematurely born infants. Treatment regimens usually consist of high doses of DEX for several weeks, notably during a critical period of brain development. Therefore, there is some concer...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Kan-Hsun, Yeh, Che-Ming, Yeh, Chia-Yu, Huang, Chiung-Chun, Hsu, Kuei-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637314/
https://www.ncbi.nlm.nih.gov/pubmed/23594486
http://dx.doi.org/10.1186/1756-6606-6-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637314/
https://www.ncbi.nlm.nih.gov/pubmed/23594486
http://dx.doi.org/10.1186/1756-6606-6-18

Ejemplares similares